Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 46Lung Neoplasms 29Neoplasms 26Colorectal Neoplasms 21Prostatic Neoplasms 16Uterine Cervical Neoplasms 9Fatigue 9Hematologic Neoplasms 8Lymphoma 7Hematopoietic and Lymphatic System Neoplasm 7Anxiety Disorders 7Papillomavirus Infections 6Melanoma 6Neoplasm Metastasis 5Multiple Myeloma 5Gastrointestinal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Skin Neoplasms 4Ovarian Neoplasms 4Obesity-Related Malignant Neoplasm 4Obesity 4Motor Activity 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Depression 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3

Interventions

Ultrasonic Waves 1Tobacco Use Cessation Devices 1Therapeutics 1Surveys and Questionnaires 1Patient Reported Outcome Measures 1Nicotine Replacement Therapy 1Nicotine Chewing Gum 1Ethanol 1Educational Status 1Dosage Forms 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Substance-Related Disorders × Educational Status × Clear all
NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡